PUEBLO — If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound’s immense potential as medicine, the “father of cannabis research” said Saturday.

PUEBLO — If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound’s immense potential as medicine, the “father of cannabis research” said Saturday.

Rescheduling will not shut down the thousands of existing medical (or for that matter recreational) grows, processing facilities and dispensaries that serve people in about half of the U.S.

Rescheduling will not shut down the thousands of existing medical (or for that matter recreational) grows, processing facilities and dispensaries that serve people in about half of the U.S.

Updated: A spokeswoman for U.S. Sen. Johnny Isakson clarified that the Republican only supports rescheduling cannabis oil under the U.S. Drug Enforcement Administration’s system, not marijuana more broadly.

Democratic presidential candidate Hillary Clinton plans to reschedule marijuana if she is elected in November, according to a statement issued by the campaign.

Democratic presidential candidate Hillary Clinton plans to reschedule marijuana if she is elected in November, according to a statement issued by the campaign.

Democratic nominee Hillary Clinton and Republican nominee Donald Trump will have their first of three debates on Monday.

Democratic nominee Hillary Clinton and Republican nominee Donald Trump will have their first of three debates on Monday.

The latest marijuana-centric bill before Congress would place cannabis as a Schedule III substance, a classification shared by Tylenol with codeine, ketamine and dronabinol.

Bruce Kennedy ~ WeedWorthy.com ~

A group of U.S. lawmakers is calling on the U.S. Drug Enforcement Administration (DEA) of remove federal barriers on medical marijuana research and to ease new medical research on cannabis and its derivatives.

Bruce Kennedy ~ WeedWorthy.com ~

A group of U.S. lawmakers is calling on the U.S. Drug Enforcement Administration (DEA) of remove federal barriers on medical marijuana research and to ease new medical research on cannabis and its derivatives.